Senior Director
Johnson and Johnson
Liping Zhang, Ph.D, FCP
Liping Zhang, Ph.D., FCP, is a seasoned pharmacometrician and drug developer with over 20 years of experience advancing therapies for pediatric populations. As Senior Director on Janssen’s Pediatric Strategy Team at Johnson & Johnson (JNJ) Innovative Medicine, she leads efforts to design innovative, efficient, and regulatory-compliant pediatric drug development programs across therapeutic areas.
Liping’s expertise lies in integrating modeling and simulation, clinical trial extrapolation, regulatory science, trial execution, and financial strategies to streamline development and improve patient outcomes. She is known for applying quantitative methods to optimize dosing strategies and study designs, ensuring that pediatric trials are both scientifically rigorous and operationally feasible.
Disclosure(s): No financial relationships to disclose
Wednesday, November 13, 2024
10:45 AM – 12:15 PM MST
Wednesday, November 13, 2024
11:35 AM – 11:50 AM MST